Lifeline Biotechnologies Inc
Lifeline Biotechnologies, Inc. operates as a medical technology company in the United States. Its technologies focus on prevention, early diagnosis, and quick recovery of various diseases. The company offers First Warning System, a non-invasive, non-compressive, and non-radiogenic device used in assisting the early discovery of breast tissue abnormalities in women. It also provides Mastascope, a … Read more
Market Cap & Net Worth: Lifeline Biotechnologies Inc (LLBO)
Lifeline Biotechnologies Inc (PINK:LLBO) has a market capitalization of $434.89K ($434.89K) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #51187 globally and #15856 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Lifeline Biotechnologies Inc's stock price $0.00 by its total outstanding shares 4348921001 (4.35 Billion).
Lifeline Biotechnologies Inc Market Cap History: 2015 to 2025
Lifeline Biotechnologies Inc's market capitalization history from 2015 to 2025. Data shows change from $10.87 Million to $434.89K (-28.20% CAGR).
Lifeline Biotechnologies Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Lifeline Biotechnologies Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
23.61x
Lifeline Biotechnologies Inc's market cap is 23.61 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
34.16x
Lifeline Biotechnologies Inc's market cap is 34.16 times its annual earnings
1.95x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $10.87 Million | $65.00K | $2.62K | 167.26x | 4157.67x |
| 2016 | $3.48 Million | $60.01K | $5.94K | 57.98x | 586.01x |
| 2017 | $8.26 Million | $350.00K | $241.91K | 23.61x | 34.16x |
Competitor Companies of LLBO by Market Capitalization
Companies near Lifeline Biotechnologies Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Lifeline Biotechnologies Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Lifeline Biotechnologies Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Lifeline Biotechnologies Inc's market cap moved from $10.87 Million to $ 434.89K, with a yearly change of -28.20%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $434.89K | 0.00% |
| 2024 | $434.89K | -50.00% |
| 2023 | $869.78K | -33.33% |
| 2022 | $1.30 Million | +50.00% |
| 2021 | $869.78K | -60.00% |
| 2020 | $2.17 Million | -37.50% |
| 2019 | $3.48 Million | -75.00% |
| 2018 | $13.92 Million | +68.42% |
| 2017 | $8.26 Million | +137.50% |
| 2016 | $3.48 Million | -68.00% |
| 2015 | $10.87 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Lifeline Biotechnologies Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $434.89K USD |
| MoneyControl | $434.89K USD |
| MarketWatch | $434.89K USD |
| marketcap.company | $434.89K USD |
| Reuters | $434.89K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.